Role of the IL33/Amphiregulin Pathway as a Potential Therapeutic Target in HIV Infection

Clinical trial NCT03622177 · UNKNOWN

Trial details

NCT number: NCT03622177
Sponsor: ANRS, Emerging Infectious Diseases
Status: UNKNOWN
Study type: OBSERVATIONAL

HIV I Infection

Start date: 2018-09-01
Primary completion: 2019-09-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.